Skip to main content
Clinical Trials/RBR-3vmy6sq
RBR-3vmy6sq
Completed
N/A

Evaluation of the effectiveness of Psychotherapy in the period of the COVID-19 pandemic

APHETO - Laboratório de Psicopatologia e Clínica Humanista Fenomenológica0 sitesOctober 6, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Psychological Distress
Sponsor
APHETO - Laboratório de Psicopatologia e Clínica Humanista Fenomenológica
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Objective: The aim of this study was to evaluate, through a randomized clinical trial, the use of outcome monitoring and feedback system routines in psychotherapy processes conducted in a university psychology clinic (UPC) with people who presented emotional distress during the COVID-19 pandemic. Method: Participants (N=90) were divided into two groups: Experimental and Control. For patients in the Experimental Group, routine outcome monitoring (ROM) and feedback system (FS) were used, in which psychotherapists incorporated into their clinical practice a dialogue with patients about their answers to questionnaires. Results: After 6 months of intervention, we identified that there were significant changes between the first and the last application of the Outcome Questionnaire-45.2 (OQ®-45.2) in the psychotherapeutic process (F(3, 85) = 4,267, p < 0.01). However, there are no differences between the Experimental Group and the Control Group (F(3, 85) = 0.417, p = 0.741). Conclusion: Although no significant differences were found, it is possible to conclude that psychotherapy was effective for both groups. The use of ROM and FS in a Brazilian UPC proved to be a challenge, but at the same time, it is a way to develop a culture of research that can help beginning psychotherapists to improve results.

Registry
who.int
Start Date
October 6, 2023
End Date
February 28, 2022
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
APHETO - Laboratório de Psicopatologia e Clínica Humanista Fenomenológica

Eligibility Criteria

Inclusion Criteria

  • Persons over 18 years of age; Be registered with the Unified Health System (SUS); Be regulated in the SPA\-NAMI system (study site); Present emotional distress in the COVID\-19 pandemic period, through self\-report in screening; Have availability for weekly psychotherapeutic care, with an average duration of 50 minutes, for six months remote or in person; Possess cognitive ability that allows the understanding and completion of the OQ®\-45\.2 and OQ®\-ASC research instruments

Exclusion Criteria

  • Participants who were experiencing a severe emotional crisis related to a moderate or severe psychiatric disorder, which made systematic psychotherapeutic follow\-up impossible; Patients who were already undergoing psychotherapeutic follow\-up with another professional

Outcomes

Primary Outcomes

Not specified

Similar Trials